Afonso, J.; Barbosa-Matos, C.; Silvestre, R.; Pereira-Vieira, J.; Gonçalves, S.M.; Mendes-Alves, C.; Parpot, P.; Pinto, J.; Carapito, Â.; Guedes de Pinho, P.;
et al. Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect. Cancers 2024, 16, 1418.
https://doi.org/10.3390/cancers16071418
AMA Style
Afonso J, Barbosa-Matos C, Silvestre R, Pereira-Vieira J, Gonçalves SM, Mendes-Alves C, Parpot P, Pinto J, Carapito Â, Guedes de Pinho P,
et al. Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect. Cancers. 2024; 16(7):1418.
https://doi.org/10.3390/cancers16071418
Chicago/Turabian Style
Afonso, Julieta, Catarina Barbosa-Matos, Ricardo Silvestre, Joana Pereira-Vieira, Samuel Martins Gonçalves, Camille Mendes-Alves, Pier Parpot, Joana Pinto, Ângela Carapito, Paula Guedes de Pinho,
and et al. 2024. "Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect" Cancers 16, no. 7: 1418.
https://doi.org/10.3390/cancers16071418
APA Style
Afonso, J., Barbosa-Matos, C., Silvestre, R., Pereira-Vieira, J., Gonçalves, S. M., Mendes-Alves, C., Parpot, P., Pinto, J., Carapito, Â., Guedes de Pinho, P., Santos, L., Longatto-Filho, A., & Baltazar, F.
(2024). Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect. Cancers, 16(7), 1418.
https://doi.org/10.3390/cancers16071418